Impact of Preoperative Suspension of Antiplatelet Therapy on Thrombotic Events Following Minimally Invasive Surgery for Abdominopelvic Cancer in Patients Using P2Y12 Inhibitors - Poll - MDSpire

Impact of Preoperative Suspension of Antiplatelet Therapy on Thrombotic Events Following Minimally Invasive Surgery for Abdominopelvic Cancer in Patients Using P2Y12 Inhibitors

  • By

  • Masashi Kubota

  • Satomi Yoshida

  • Takayuki Goto

  • Toshiki Fukasawa

  • Takayuki Anno

  • Gaku Fujiwara

  • Satoshi Toshiyama

  • Yoshihide Inayama

  • Takanori Yanai

  • Takayuki Sumiyoshi

  • Ryoichi Saito

  • Takashi Kobayashi

  • Koji Kawakami

  • January 16, 2026

  • 0 min

Share

Original Source(s)

Impact of Preoperative Suspension of Antiplatelet Therapy on Thrombotic Events Following Minimally Invasive Surgery for Abdominopelvic Cancer in Patients Using P2Y12 Inhibitors

  • by Masashi Kubota, Satomi Yoshida, Takayuki Goto, Toshiki Fukasawa, Takayuki Anno, Gaku Fujiwara, Satoshi Toshiyama, Yoshihide Inayama, Takanori Yanai, Takayuki Sumiyoshi, Ryoichi Saito, Takashi Kobayashi, Koji Kawakami

  • January 16, 2026

Related Content

PFO closure in ischemic stroke: insights from a single-center real-world cohort

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.